Cancer Vaccine Acceleration Fund

The Cancer Vaccine Acceleration Fund (CVAF) is a non-profit venture fund established by the Cancer Research Institute (CRI) in collaboration with the Ludwig Institute for Cancer Research. The fund was created to bridge the gap between laboratory discovery and clinical application by providing the necessary capital and resources for early-stage clinical trials of promising cancer immunotherapies. CVAF focuses on accelerating the development of therapeutic vaccines and combination treatments that utilize the body's immune system to fight cancer. By partnering with biotech companies and academic researchers, the fund helps de-risk innovative technologies and move them toward commercialization. The initiative has since evolved into the CRI Clinical Accelerator, which continues to manage a robust portfolio of immunotherapy trials.